Delivery Order SPE2DB20D2104-SPE2DB21FT86R
Award Date
9/2/21
Potential Completion Date
9/3/21
Potential Value
$5.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,026.52, is for the delivery of the drug BIDIL 20 MG-37.5 MG TABLET 90S. It is a firm-fixed-price contract with a completion date of November 6, 2024. This award is not designated as a set-aside contract. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,123.63 firm fixed-price delivery order is for the supply of BIDIL 20 MG-37.5 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of March 28, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,043.62 firm fixed-price delivery order contract is for the supply of BIDIL 20 MG-37.5 MG TABLET 90S, a pharmaceutical product. The contract has a performance period ending on May 31, 2023 and was awarded on May 30, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of BIDIL 20 MG-37.5 MG TABLET 90S to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,361.42 and an ultimate completion date of October 21, 2021. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which is the parent company. This contract is a delivery order under a larger Indefinite...
This federal contract award, valued at $2,496.81, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4557100894 BIDIL 20 MG-37.5 MG TABLET 90S. The contract is a Firm Fixed Price Delivery Order with a completion date of May 5, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has established itself as a key vendor for federal healthcare programs, particularly within...
The Defense Logistics Agency Troop Support Medical awarded a $6,286.72 firm fixed price delivery order contract to Amerisourcebergen Drug Corporation for 90 tablets of BIDIL 20 MG-37.5 MG to be delivered to its Conshohocken, Pennsylvania facility by September 8, 2023. The contract was awarded utilizing the Medical-Surgical Federal Supply Schedule, a multiple award indefinite delivery/indefinite quantity contract vehicle managed by the Defense Logistics Agency Troop Support Medical to provide...
The Defense Logistics Agency awarded a $4,865.07 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the provision of 4561463344 BIDIL 20 MG-37.5 MG tablets. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will deliver 90 tablets to a location in Conshohocken, Pennsylvania by July 12, 2023 to fulfill requirements under the order. As the DLA supports procurement for the Department of Defense, this contract for pharmaceutical products is...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,101.54 firm fixed-price delivery order contract is for the supply of AMLODIPINE-OLMESARTAN 10-40 MG 30S, a cardiovascular medication, to support military healthcare programs. The contract has an ultimate completion date of November 19, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order, valued at $19,495.48, is for the delivery of AMLOD-VALSA-HCTZ 10-320-25 MG 30S pharmaceutical products. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,609.19 firm-fixed-price contract is for the delivery of BENICAR HCT 40-12.5 MG TABLET 30S, a cardiovascular medication, to support military and veterans' healthcare programs. The contract has a performance period through January 8, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...